Increased expression of tight junction protein occludin is associated with the protective effect of mosapride against aspirin‑induced gastric injury

  • Authors:
    • Chenchen Liu
    • Zhaotao Duan
    • Yue Guan
    • Hailu Wu
    • Kewei Hu
    • Xin Gao
    • Fangcen Yuan
    • Zongdan Jiang
    • Ye Fan
    • Bangshun He
    • Shukui Wang
    • Zhenyu Zhang
  • View Affiliations

  • Published online on: November 23, 2017     https://doi.org/10.3892/etm.2017.5550
  • Pages: 1626-1632
Metrics: HTML 0 views | PDF 0 views     Cited By (CrossRef): 0 citations

Abstract

Mosapride is known to affect gastric motility, however whether mosapride has anti‑ulcergenic effects in gastric mucosal injury is unclear. The aim of the present study was to investigate the effects of mosapride on aspirin‑induced gastric injuries. GES‑1 cells were cultured and divided into 5 groups: Control group, aspirin injury group (treated with 18.2 mmol/l aspirin) and mosapride pretreatment groups (treated with 0.4, 0.5, or 0.6 µmol/l mosapride). Cell proliferation was evaluated via MTT assay and cell apoptosis was investigated via flow cytometry. The expression of occludin was determined by western blot analysis. A total of 40 male Sprague‑Dawley rats were randomized into five groups: Control group, aspirin injury group (150 mg/kg) and mosapride pretreatment groups (0.25, 0.50 or 0.75 mg/kg). Gastric mucosal lesions were induced by administering 200 mg/kg aspirin daily for 4 days. Rats in the mosapride groups were pretreated with mosapride 1 h prior to aspirin administration. Histological changes were evaluated under a light microscope and gastric epithelial TJs were observed via transmission electron microscopy. The results revealed that cell apoptosis was significantly increased in the aspirin injury group compared with the control (P<0.05), whereas apoptosis was significantly decreased in the mosapride pretreatment groups compared with the aspirin group (P<0.05). Cell viability was significantly increased in the mosapride pretreatment groups compared with the aspirin injury group (P<0.05), and that of the aspirin injury group was significantly decreased compared with the control group (P<0.05). Compared with the aspirin injury group, occludin expression was significantly increased in the three mosapride pre‑treatment groups (all P<0.05). It was also demonstrated that gastric damage was significantly attenuated in the mosapride pretreatment groups compared with the aspirin injury group (P<0.05). Impaired TJ integrity was observed in aspirin injury group, whereas TJs in the mosapride groups were almost intact. In conclusion, the results of the present study suggest that mosapride exerts a gastroprotective action on aspirin‑induced gastric mucosal injury at least in part via attenuating cell apoptosis and increasing occludin expression.

Related Articles

Journal Cover

February 2018
Volume 15 Issue 2

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Liu, C., Duan, Z., Guan, Y., Wu, H., Hu, K., Gao, X. ... Zhang, Z. (2018). Increased expression of tight junction protein occludin is associated with the protective effect of mosapride against aspirin‑induced gastric injury. Experimental and Therapeutic Medicine, 15, 1626-1632. https://doi.org/10.3892/etm.2017.5550
MLA
Liu, C., Duan, Z., Guan, Y., Wu, H., Hu, K., Gao, X., Yuan, F., Jiang, Z., Fan, Y., He, B., Wang, S., Zhang, Z."Increased expression of tight junction protein occludin is associated with the protective effect of mosapride against aspirin‑induced gastric injury". Experimental and Therapeutic Medicine 15.2 (2018): 1626-1632.
Chicago
Liu, C., Duan, Z., Guan, Y., Wu, H., Hu, K., Gao, X., Yuan, F., Jiang, Z., Fan, Y., He, B., Wang, S., Zhang, Z."Increased expression of tight junction protein occludin is associated with the protective effect of mosapride against aspirin‑induced gastric injury". Experimental and Therapeutic Medicine 15, no. 2 (2018): 1626-1632. https://doi.org/10.3892/etm.2017.5550